Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the webspellchecker domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gulfindex35/public_html/ijpcs.net/wp-includes/functions.php on line 6121
Pharmacist’s Awareness and Knowledge of Reporting Adverse Drug Reactions in Saudi Arabia – IJPCS
Articles

Pharmacist’s Awareness and Knowledge of Reporting Adverse Drug Reactions in Saudi Arabia

Written by admin

International Journal of Pharmacology and Clinical Sciences, 2019, 8, 1, 60-65.
DOI: 10.5530/ijpcs.2019.8.11
Published: January 2019
Type: Research Article
Authors: Fatimah Fouad Al Doughan, Yousef Ahmed Alomi, and Mais Hasan Iflaifel
Author(s) affiliations:

Fatimah Fouad Al Doughan1,*, Yousef Ahmed Alomi2, Mais Hasan Iflaifel3

1Pharmacy Practice Department, College of Clinical Pharmacy, King Faisal University, Alahsaa, SAUDI ARABIA.
2The Former General Manager of General Administration of Pharmaceutical Care and Former Head, National Clinical Pharmacy and Pharmacy Practice and Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA.
3Pharmacy Practice Department, College of Clinical Pharmacy, King Faisal University, Alahsaa, SAUDI ARABIA.

Abstract

Objectives: Pharmacovigilance is considered a useful tool in detecting, assessing, understanding, and preventing Adverse Drug Reactions (ADRs) to ensure the safety of medications and protect consumers from ADRs. Consequently, the progression and expansion of pharmacovigilance is urgent for safe and effective clinical practice; therefore, in this study, we aimed to compare the awareness and knowledge of the community and hospital pharmacists toward reporting ADRs in different regions of Saudi Arabia. Methods: This cross-sectional study was conducted from January 2016 to March 2016 in Saudi Arabia. A validated and structured questionnaire was distributed by hand or via Internet to 263 hospital and community pharmacists. The questionnaire collected pharmacists’ demographic information and pharmacists’ understanding and knowledge of the pharmacovigilance system and reporting of ADRs. Results: A total of 263 pharmacists responded to the questionnaire with 208 (79.09%) pharmacists from hospital pharmacy sites and 55 (20.91%) pharmacists from community pharmacy responding to the questionnaire. There is a significant difference in the pharmacovigilance concept (p<0.05) between the hospital and community pharmacists. Most community pharmacists were unfamiliar with the existence of a pharmacovigilance center in Saudi Arabia. Furthermore, community pharmacists were unaware of where they could get an ADR reporting form, but hospital pharmacists were aware of this (p<0.05). Conclusion: The results of this study demonstrated that pharmacists who work at hospitals among different regions in Saudi Arabia had a higher awareness of the pharmacovigilance system than that of community pharmacists who worked at the community pharmacy.

Keywords: Adverse drug reactions, Awareness, Knowledge, Pharmacists, Pharmacovigilance, Saudi Arabia